Abstract
Patients with COVID-19 ARDS have distinct physiological and immunological phenotypes compared to patients with non-COVID ARDS. Patients with COVID-19 ARDS (n = 32) had a significant improvement in PaO 2 : FiO 2 ratio (p = 0.046) following low-dose steroid treatment, unlike patients with non-COVID ARDS (n = 16) (p = 0.529). Patients with COVID-19 ARDS had a greater fall in CRP compared to patients with non-COVID ARDS, albeit not statistically significant (p = 0.07). Our novel findings highlight differences in the underlying physiological and immunological phenotypes between COVID-19 and non-COVID ARDS, with implications for future ARDS studies.
Keywords: ARDS; COVID-19; Inflammation; Steroids.
【저자키워드】 COVID-19, Inflammation, ARDS, Steroids, 【초록키워드】 CRP, low-dose, Patient, physiological, immunological phenotype, implication, highlight, steroid treatment, greater, statistically significant, PaO, with COVID-19, 【제목키워드】 Steroids, low dose, retrospective, ARDS patient,